Immunic, Inc. (NASDAQ:IMUX) Receives $12.67 Consensus Target Price from Analysts
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are ...
EQS-News: Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Immunic, Inc. to Participate in Scientific and Industry Conferences in April ...
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
Immunic (IMUX) Has a New Rating from William Blair
Immunic (IMUX – Research Report) received a Buy rating and a $1.20 price target from William Blair analyst Matt Phipps yesterday. The company’s ...
Analysts Set Expectations for Immunic FY2026 Earnings
Analysts at William Blair issued their FY2026 EPS estimates for shares of Immunic in a research note issued to investors on ...
North American Morning Briefing: Trump Tariffs -2-
Lundin Mining Announces New Shareholder Distribution Policy; Adjusting Quarterly Dividend to C$0.0275/Share From C$0.09/Share; Allocating Up to Around $150M Per Year in Share Buybacks; Committed to ...